By Stephen Nakrosis

Teva Pharmaceuticals USA, Inc. on Tuesday said the U.S. Food and Drug Administration has granted approval to an autoinjector device for Ajovy, or fremanezumab-vfrm.

Ajovy is a medication used to prevent migraines.

The Ajovy autoinjector is expected to be available to patients in the coming months.

Teva Pharmaceuticals USA, Inc. is an affiliate of Teva Pharmaceutical Industries Ltd. (TEVA).

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

January 28, 2020 17:01 ET (22:01 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Teva Pharmaceutical Indu... Charts.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Teva Pharmaceutical Indu... Charts.